Log in
Enquire now
‌

US Patent 12083270 Delivery device and method

Patent 12083270 was granted and assigned to OptiNose on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
OptiNose
OptiNose
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120832700
Patent Inventor Names
Roderick Peter Hafner0
Colin David Sheldrake0
Per Gisle Djupesland0
Date of Patent
September 10, 2024
0
Patent Application Number
122792850
Date Filed
February 14, 2007
0
Patent Citations
‌
US Patent 9119932 Nasal delivery device
0
‌
US Patent 9168341 Delivery devices
0
‌
US Patent 9205208 Nasal devices
0
‌
US Patent 9205209 Delivery device and method
0
‌
US Patent 9272104 Nasal delivery
0
‌
US Patent D759805 Nosepiece unit
0
‌
US Patent D761951 Nosepiece unit
0
‌
US Patent D530815 Nasal delivery device
0
...
Patent Primary Examiner
‌
Annette Dixon
0
Patent abstract

A nasal delivery device for and method of delivering substance to the middle meatus in a nasal cavity of a subject in the treatment of a condition, in particular an inflammatory or infectious condition, thereof, the delivery device comprising: a nosepiece unit (

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12083270 Delivery device and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.